Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 9140541, 12 pages
http://dx.doi.org/10.1155/2016/9140541
Research Article

Therapeutic Effects of CUR-Activated Human Umbilical Cord Mesenchymal Stem Cells on 1-Methyl-4-phenylpyridine-Induced Parkinson’s Disease Cell Model

1Neurology Department of General Hospital of Jinan Military Region, Jinan, Shandong 250031, China
2The Neurology Department, The 148th Hospital, Zibo, Shandong 255300, China
3Sanbo Brain Hospital Capital Medical University, Haidian District, Beijing 100093, China
4Medical School of Henan University, Zhengzhou, Henan 475000, China
5Neurology Department, The Second Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450014, China
6Department of Medicine, The University of Chicago, Chicago, IL 60637, USA

Received 23 November 2015; Revised 2 March 2016; Accepted 27 March 2016

Academic Editor: Nicola Simola

Copyright © 2016 Li Jinfeng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Pluck and R. G. Brown, “Apathy in Parkinson's disease,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 73, no. 6, pp. 636–642, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Yarnall, L. Rochester, and D. J. Burn, “Mild cognitive impairment in parkinson's disease,” Age and Ageing, vol. 42, no. 5, pp. 567–576, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Kuramoto, J. Cragg, R. Nandhagopal et al., “The nature of progression in parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling,” PLoS ONE, vol. 8, no. 10, Article ID e76595, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Nóbrega, P. Pinho, M. Deiró, and N. Argolo, “Levodopa treatment in Parkinson's disease: how does it affect dysphagia management?” Parkinsonism and Related Disorders, vol. 20, no. 3, pp. 340–341, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Yamada, S. Goto, J.-I. Kuratsu et al., “Stereotactic surgery for subthalamic nucleus stimulation under general anesthesia: a retrospective evaluation of Japanese patients with Parkinson's disease,” Parkinsonism and Related Disorders, vol. 13, no. 2, pp. 101–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Deuschl, J. Herzog, G. Kleiner-Fisman et al., “Deep brain stimulation: postoperative issues,” Movement Disorders, vol. 21, no. 14, pp. S219–S237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Bjorklund and J. H. Kordower, “Cell therapy for Parkinson's disease: what next?” Movement Disorders, vol. 28, no. 1, pp. 110–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Sharma, C. R. McMillan, and L. P. Niles, “Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease,” Journal of Pineal Research, vol. 43, no. 3, pp. 245–254, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. D. F. Emerich, “Cell transplantation for Parkinson's disease,” Cell Transplantation, vol. 11, no. 1, pp. 1–3, 2002. View at Google Scholar · View at Scopus
  10. M. Yan, M. Sun, Y. Zhou et al., “Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model,” PLoS ONE, vol. 8, no. 5, Article ID e64000, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-F. Li, H.-L. Yin, A. Shuboy et al., “Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor,” Molecular and Cellular Biochemistry, vol. 381, no. 1-2, pp. 183–190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-S. Liu, J.-F. Li, S.-S. Wang et al., “Human umbilical cord mesenchymal stem cells infected with adenovirus expressing HGF promote regeneration of damaged neuron cells in a Parkinson's disease model,” BioMed Research International, vol. 2014, Article ID 909657, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Tizabi, L. L. Hurley, Z. Qualls, and L. Akinfiresoye, “Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression,” Molecules, vol. 19, no. 12, pp. 20864–80879, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Jaisin, A. Thampithak, B. Meesarapee et al., “Curcumin I protects the dopaminergic cell line SH-SY5Y from 6-hydroxydopamine-induced neurotoxicity through attenuation of p53-mediated apoptosis,” Neuroscience Letters, vol. 489, no. 3, pp. 192–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Qualls, D. Brown, C. Ramlochansingh, L. L. Hurley, and Y. Tizabi, “Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for parkinson's disease,” Neurotoxicity Research, vol. 25, no. 1, pp. 81–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. H. Siddique, F. Naz, and S. Jyoti, “Effect of curcumin on lifespan, activity pattern, oxidative stress, and apoptosis in the brains of transgenic drosophila model of Parkinson's disease,” BioMed Research International, vol. 2014, Article ID 606928, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Ahmad and L. J. Lapidus, “CUR prevents aggregation in α-Synuclein by increasing reconfiguration rate,” The Journal of Biological Chemistry, vol. 287, no. 12, pp. 9193–9199, 2012. View at Google Scholar
  18. A.-L. Chen, C.-H. Hsu, J.-K. Lin et al., “Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions,” Anticancer Research B, vol. 21, no. 4, pp. 2895–2900, 2001. View at Google Scholar · View at Scopus
  19. T. Esatbeyoglu, P. Huebbe, I. M. A. Ernst, D. Chin, A. E. Wagner, and G. Rimbach, “Curcumin—from molecule to biological function,” Angewandte Chemie—International Edition, vol. 51, no. 22, pp. 5308–5332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. L.-H. Zhu, X. Bai, N. Zhang, S.-Y. Wang, W. Li, and L. Jiang, “Improvement of human umbilical cord mesenchymal stem cell transplantation on glial cell and behavioral function in a neonatal model of periventricular white matter damage,” Brain Research, vol. 1563, pp. 13–21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. F. Li, D. J. Zhang, T. Geng et al., “The potential of human umbilical cord-derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis,,” Cell Transplantation, vol. 23, supplement 1, pp. S113–S122, 2014. View at Publisher · View at Google Scholar
  22. M. L. Weiss, S. Medicetty, A. R. Bledsoe et al., “Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease,” Stem Cells, vol. 24, no. 3, pp. 781–792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Chen, X. Q. Tang, J. L. Zhi et al., “Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway,” Apoptosis, vol. 11, no. 6, pp. 943–953, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Yang, S. Song, J. Li, and T. Liang, “Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat,” Pathology Research and Practice, vol. 210, no. 6, pp. 357–362, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Lv, J. Liu, L. Wang et al., “Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson’s disease,” Cell Biochemistry and Biophysics, vol. 70, no. 2, pp. 1433–1438, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Wang, J. Gao, Y. Miao et al., “Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway,” Journal of Molecular Neuroscience, vol. 53, no. 4, pp. 537–545, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Wu, O. W. Wan, and K. K. K. Chung, “S-nitrosylation of XIAP at Cys 213 of BIR2 domain impairs XIAP's anti-caspase 3 activity and anti-apoptotic function,” Apoptosis, vol. 20, no. 4, pp. 491–499, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Corbitt, T. Hagerty, E. Fernandez, W. W. Morgan, and R. Strong, “Transcriptional and post-transcriptional regulation of tyrosine hydroxylase messenger RNA in PC12 cells during persistent stimulation by VIP and PACAP38: differential regulation by protein kinase A and protein kinase C-dependent pathways,” Neuropeptides, vol. 36, no. 1, pp. 34–45, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Storch, A. C. Ludolph, and J. Schwarz, “Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration,” Journal of Neural Transmission, vol. 111, no. 10, pp. 1267–1286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Cho, Y.-K. Seo, S. Jeon, H.-H. Yoon, Y.-K. Choi, and J.-K. Park, “Neural differentiation of umbilical cord mesenchymal stem cells by sub-sonic vibration,” Life Sciences, vol. 90, no. 15-16, pp. 591–599, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Yan, K. O. Skaftnesmo, L. Leiss et al., “Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide,” BMC Cancer, vol. 11, article 524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Barcia, C. M. Ros, V. Annese et al., “IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease,” Cell Death and Disease, vol. 3, no. 8, article e382, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. D. D. Lofrumento, G. Nicolardi, A. Cianciulli et al., “Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses,” Innate Immunity, vol. 20, no. 3, pp. 249–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Haddadi, A. Mohajjel Nayebi, and S. E. Brooshghalan, “Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats,” Neuroscience Letters, vol. 555, pp. 106–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. A. Beharka, M. Meydani, D. Wu, L. S. Leka, A. Meydani, and S. N. Meydani, “Interleukin-6 production does not increase with age,” Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 56, no. 2, pp. B81–B88, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Müller, D. Blum-Degen, H. Przuntek, and W. Kuhn, “Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease,” Acta Neurologica Scandinavica, vol. 98, no. 2, pp. 142–144, 1998. View at Google Scholar · View at Scopus
  37. R. A. Gadient and U. H. Otten, “Interleukin-6 (IL-6)—a molecule with both beneficial and destructive potentials,” Progress in Neurobiology, vol. 52, no. 5, pp. 379–390, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Infante, I. García-Gorostiaga, P. Sánchez-Juan et al., “Inflammation-related genes and the risk of Parkinson's disease: a multilocus approach,” European Journal of Neurology, vol. 15, no. 4, pp. 431–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Vasseur, I. Devaure, J. Sellier et al., “High plasma levels of the pro-inflammatory cytokine IL-22 and the anti-inflammatory cytokines IL-10 and IL-1ra in acute pancreatitis,” Pancreatology, vol. 14, no. 6, pp. 465–469, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. Z.-K. Xiong, J. Lang, G. Xu et al., “Excessive levels of nitric oxide in rat model of parkinson's disease induced by rotenone,” Experimental and Therapeutic Medicine, vol. 9, no. 2, pp. 553–558, 2015. View at Publisher · View at Google Scholar · View at Scopus